Elicio Therapeutics (ELTX) Cash from Operations (QoQ) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Elicio Therapeutics | 217.63 Mn | 202.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -71.33% |
| Dec 31, 2025 | 38.69% |
| Sep 30, 2025 | -23.87% |
| Jun 30, 2025 | 11.55% |
| Mar 31, 2025 | -15.73% |
| Dec 31, 2024 | -20.21% |
| Sep 30, 2024 | 18.53% |
| Jun 30, 2024 | 26.35% |
| Mar 31, 2024 | -22.51% |
| Dec 31, 2023 | -90.84% |
| Sep 30, 2023 | 45.28% |
| Jun 30, 2023 | -16.41% |
| Mar 31, 2023 | -11.86% |
| Dec 31, 2022 | -35.09% |
| Sep 30, 2022 | -187.78% |
| Jun 30, 2022 | 139.20% |
| Mar 31, 2022 | -8.99% |
| Dec 31, 2021 | 5.51% |
| Sep 30, 2021 | -44.33% |
| Jun 30, 2021 | 16.09% |
| Mar 31, 2021 | -160.95% |
| Dec 31, 2020 | 193.84% |
| Sep 30, 2020 | -71.37% |
| Jun 30, 2020 | -46.62% |